BioSpace News Archive

DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced the closing of its previously announced registered direct offering of 1,170,000 shares of common stock and, in a concurrent private placement

BRAINBox Solutions today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company’s BRAINBox TBI (Traumatic Brain Injury) test in development, the first to aid in both the diagnosis and prognosis of mild TBI (concussion).

Eastern Nephrology Associates (ENA) has announced its merger with Southeastern Nephrology Associates (SENA) effective June 1st.

Pelican BioThermal, the global name in temperature-controlled packaging, announces the opening of a new network station and service center in Mexico City, Mexico. Mexico is the second largest pharmaceutical market in Latin America — and 12th in the world — with more than $1.75 billion in pharmaceutical exports since 2015.

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, announces the Company has received its latest research unit order for a 9820 Xenon Polariser system from The Hospital for Sick Children (“SickKids”) in Toronto www.sickkids.ca.

Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, today announced that the first patient has been dosed in its pivotal Phase 3 psoriasis clinical program, PSOARING, for its lead product candidate, tapinarof. Tapinarof is a therapeutic aryl hydrocarbon receptor modulating agent (TAMA) topical cream being developed by Dermavant for plaque psoriasis and atopic dermatitis

Owlstone Medical, a global diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, announced today the formation of a partnership with the International Association of Heat and Frost Insulators and Allied Workers (IAHFIAW), formerly known as the Asbestos Workers, a building trades union in the United States and Canada, to identify and verify breath-based biomarkers for the early detection of malignant mesothelioma.

Gemini Bio-Products, LLC (“Gemini” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced the appointment of two new members of the senior executive team.

Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people with head and neck cancer that has returned than standard aggressive chemotherapy, new clinical trial results show.

The following is a statement from Carl Anderson, Supreme Knight, Knights of Columbus, on HHS Action to End NIH Research on Fetal Tissue Obtained from Abortions